Virtus ETF Advisers’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,362
| Closed | -$343K | – | 483 |
|
|
2023
Q2 | $343K | Buy |
3,362
+488
| +17% | +$49.8K | 0.2% | 162 |
|
|
2023
Q1 | $261K | Sell |
2,874
-1,101
| -28% | -$100K | 0.14% | 273 |
|
|
2022
Q4 | $151K | Buy |
3,975
+371
| +10% | +$14.1K | 0.08% | 342 |
|
|
2022
Q3 | $91K | Buy |
3,604
+25
| +0.7% | +$631 | 0.04% | 425 |
|
|
2022
Q2 | $109K | Sell |
3,579
-1,785
| -33% | -$54.4K | 0.04% | 411 |
|
|
2022
Q1 | $176K | Sell |
5,364
-320
| -6% | -$10.5K | 0.08% | 207 |
|
|
2021
Q4 | $150K | Buy |
5,684
+4,198
| +283% | +$111K | 0.06% | 350 |
|
|
2021
Q3 | $150K | Sell |
1,486
-74
| -5% | -$7.47K | 0.07% | 342 |
|
|
2021
Q2 | $221K | Sell |
1,560
-977
| -39% | -$138K | 0.09% | 272 |
|
|
2021
Q1 | $253K | Buy |
2,537
+39
| +2% | +$3.89K | 0.11% | 286 |
|
|
2020
Q4 | $309K | Buy |
2,498
+605
| +32% | +$74.8K | 0.13% | 200 |
|
|
2020
Q3 | $184K | Sell |
1,893
-253
| -12% | -$24.6K | 0.1% | 305 |
|
|
2020
Q2 | $335K | Buy |
2,146
+408
| +23% | +$63.7K | 0.16% | 279 |
|
|
2020
Q1 | $251K | Sell |
1,738
-254
| -13% | -$36.7K | 0.1% | 250 |
|
|
2019
Q4 | $407K | Sell |
1,992
-1,109
| -36% | -$227K | 0.07% | 248 |
|
|
2019
Q3 | $249K | Sell |
3,101
-172
| -5% | -$13.8K | 0.05% | 214 |
|
|
2019
Q2 | $309K | Sell |
3,273
-1,123
| -26% | -$106K | 0.07% | 203 |
|
|
2019
Q1 | $376K | Sell |
4,396
-560
| -11% | -$47.9K | 0.8% | 40 |
|
|
2018
Q4 | $278K | Sell |
4,956
-6,983
| -58% | -$392K | 0.05% | 138 |
|
|
2018
Q3 | $976K | Sell |
11,939
-8,545
| -42% | -$699K | 0.1% | 49 |
|
|
2018
Q2 | $716K | Sell |
20,484
-9,604
| -32% | -$336K | 0.63% | 93 |
|
|
2018
Q1 | $617K | Buy |
30,088
+16,171
| +116% | +$332K | 0.54% | 105 |
|
|
2017
Q4 | $394K | Buy |
13,917
+992
| +8% | +$28.1K | 0.49% | 55 |
|
|
2017
Q3 | $402K | Buy |
12,925
+1,182
| +10% | +$36.8K | 0.05% | 110 |
|
|
2017
Q2 | $372K | Sell |
11,743
-1,166
| -9% | -$36.9K | 0.06% | 80 |
|
|
2017
Q1 | $292K | Buy |
12,909
+1,237
| +11% | +$28K | 0.05% | 139 |
|
|
2016
Q4 | $255K | Buy |
+11,672
| New | +$255K | 0.08% | 135 |
|